Skip To Main Content
Yingbin Hu on Muck Rack

Yingbin Hu

As seen in: Wiley Online Library, Cell Press, Canadian Journal of Infectious Diseases & Medical Microbiology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingbin

Contact Yingbin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study

|
By Feng Wang, Gong Chen, Meng Qiu, Jinfeng Ma, Xianwei Mo, Haiyi Liu, Yongqiang Li, Peirong Ding, Yingbin Hu, Xiwen Huang, Weiqin Jiang, Xiaojun Wu, Jia Luo, Yanbing Zhou, LePing Li, Quan Wang, Nanya Wang, Wu Jiang, Weitang Yuan, Liren Li, Linlin Liu, Xianglin Yuan, Guihua Wang, Zhangfa Song, Heli Liu, Jie Ge, Yaxu Wang, Peng Zhao, Taiyuan Li, Jun You, Jianqiang Tang, Xiaobo Du, Junzhong Lin, Rongxin Zhang, Zan Fu, Jianmin Xu, Haijun Zhong, Yanhong Deng, Xiaoxiao Lu, Qun Guo, Hui Zhou, Rui-hua Xu, Xiangbin Wan, Yanlai Sun
| Cell Press Verified
Keywords anti-CLTA-4 anti-PD-1 immunotherapy microsatellite instability-high mismatch repair-deficient colon cancer Introduction Colorectal cancer (CRC) is ranked as the third most common malignant tumor and the second leading cause of cancer-related death worldwide.1 In China, there is a heavy and increasing burden of CRC, which ranks second in incidence and fourth in mortality.1 Approximately 15% of patients with CRC were found to have microsatellite instability-high or mismatch...
Open in Who Shared Issue with article?
See all 1 licensed articles (2 Total)